# Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

> **NCT00949767** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 64 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** BMS-866949
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00949767
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949767, "Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00949767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*